These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1926834)

  • 1. Prevalence of hepatitis C virus antibody in beta-thalassemic polytransfused children in a long-term follow-up.
    Resti M; Azzari C; Rossi ME; Vullo C; Borgatti L; Vierucci A
    Vox Sang; 1991; 60(4):246-7. PubMed ID: 1926834
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis G virus or hepatitis GB virus type C infection in thalassemic patients.
    Papaevangelou V; Spanou E; Kattamis C; Hadziyannis S
    Transfusion; 1999 Mar; 39(3):336-7. PubMed ID: 10204602
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Cooleycare Group.
    Rebulla P; Mozzi F; Contino G; Locatelli E; Sirchia G
    Transfus Med; 1992 Mar; 2(1):69-70. PubMed ID: 1284983
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevalence of hepatitis A antibodies in polytransfused thalassemic patients].
    Mangiagli A
    Pediatr Med Chir; 1997; 19(6):437-8. PubMed ID: 9595581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-hepatitis C virus seroconversion in polytransfused thalassemic patients.
    Borzini P; Cazzaniga G; Vecchi L
    Vox Sang; 1991; 60(3):188. PubMed ID: 1650514
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.
    Choudhry VP; Acharya SK
    Indian J Pediatr; 1995; 62(6):655-68. PubMed ID: 10829940
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion associated hepatitis C in multi-transfused thalassemic children.
    Mishra D; Pensi T
    Indian Pediatr; 2004 Mar; 41(3):287-8. PubMed ID: 15064522
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-HCV and hemoglobinopathies].
    Mattlinger B; Couroucé AM; Girot R
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):369-73. PubMed ID: 2177601
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody to hepatitis-C virus in multitransfused thalassaemics--Indian experience.
    Bhattacharya DK
    J Assoc Physicians India; 1994 Feb; 42(2):174. PubMed ID: 7532165
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C and G virus infections in polytransfused children.
    Chung JL; Kao JH; Kong MS; Yang CP; Hung IJ; Lin TY
    Eur J Pediatr; 1997 Jul; 156(7):546-9. PubMed ID: 9243238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients.
    Mihaljević I; Feldbauer J; Delajlija M; Grgicević D
    Vox Sang; 1992; 63(3):236. PubMed ID: 1333138
    [No Abstract]   [Full Text] [Related]  

  • 13. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand.
    Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C antibody (anti-HCV) prevalence in Brazilian patients with sickle cell diseases.
    Arruda VR; Eid KA; Zen GC; Gonçales NS; Saad ST; Costa FF
    Vox Sang; 1993; 65(3):247. PubMed ID: 7504375
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C virus infection in polytransfused thalassemic children in Pakistan.
    Akhtar S; Moatter T
    Indian Pediatr; 2004 Oct; 41(10):1072-3. PubMed ID: 15523144
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis in children with thalassemia major.
    Nigro G; Taliani G; Bartmann U; Vitolo R; Perrone T; Mattia S; Pisano P; Petruccelli A; Maiozzi S; Midulla M
    Arch Virol Suppl; 1992; 4():265-7. PubMed ID: 1280508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of markers for human immunodeficiency virus types 1 and 2, human T-lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. The French Study Group On Thalassaemia.
    de Montalembert M; Costagliola DG; Lefrère JJ; Cornu G; Lombardo T; Cosentino S; Perrimond H; Girot R
    Transfusion; 1992; 32(6):509-12. PubMed ID: 1323885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay.
    Lai ME; De Virgilis S; Argiolu F; Farci P; Mazzoleni AP; Lisci V; Rapicetta M; Clemente MG; Nurchis P; Arnone M
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):458-64. PubMed ID: 7686220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children.
    Lai ME; Mazzoleni AP; Argiolu F; De Virgilis S; Balestrieri A; Purcell RH; Cao A; Farci P
    Lancet; 1994 Feb; 343(8894):388-90. PubMed ID: 7905553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.